Search Results - "Aman, Enrique"

Association of PD‐L1 expression with driver gene mutations and clinicopathological characteristics in non‐small cell lung cancer: A real‐world study of 10 441 patients by Ruiz, Gonzalo, Enrico, Diego, Mahmoud, Yamil D., Ruiz, Alan, Cantarella, María Florencia, Leguina, Laura, Barberis, Mariana, Beña, Asunción, Brest, Esteban, Starapoli, Solange, Mendoza Bertelli, Andrea, Tsou, Florencia, Pupareli, Carmen, Coppola, María Pía, Scocimarro, Alejandra, Sena, Susana, Levit, Patricio, Perfetti, Aldo, Aman, Enrique, Girotti, María Romina, Arrieta, Oscar, Martín, Claudio, Salanova, Rubén

“…Background Programmed death ligand‐1 (PD‐L1) expression is a well‐known predictive biomarker of response to immune checkpoint blockade in non‐small cell lung…”
Get full text

Low activity of 13-cis-retinoic acid plus interferon alpha 2a in advanced renal cell carcinoma by JAREMTCHUK, Alejandro V, AMAN, Enrique F, PONCE, Walter, ZARBA, Juan José, FERRO, Alejandro M, ALVAREZ, Ricardo, VIGO, Silvina A

“…Retinoids and interferon alpha have shown synergistic activity against metastatic renal cell carcinoma in previous preclinical and clinical studies. Based on…”
Get full text

Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID‐19 pandemic: the THOCOoP cooperative group by Arrieta, Oscar, Cardona, Andrés F., Lara-Mejía, Luis, Heredia, David, Barrón, Feliciano, Zatarain-Barrón, Zyanya Lucia, Lozano, Francisco, de Lima, Vladmir Cordeiro, Maldonado, Federico, Corona-Cruz, Francisco, Ramos, Maritza, Cabrera, Luis, Martin, Claudio, Corrales, Luis, Cuello, Mauricio, Arroyo-Hernández, Marisol, Aman, Enrique, Bacon, Ludwing, Baez, Renata, Benitez, Sergio, Botero, Antonio, Burotto, Mauricio, Caglevic, Christian, Ferraris, Gustavo, Freitas, Helano, Kaen, Diego Lucas, Lamot, Sebastián, Lyons, Gustavo, Mas, Luis, Mata, Andrea, Mathias, Clarissa, Muñoz, Alvaro, Patane, Ana Karina, Oblitas, George, Pino, Luis, Raez, Luis E., Remon, Jordi, Rojas, Leonardo, Rolfo, Christian, Ruiz-Patiño, Alejandro, Samtani, Suraj, Viola, Lucia, Viteri, Santiago, Rosell, Rafael

“…The world currently faces a pandemic due to SARS-CoV-2. Relevant information has emerged regarding the higher risk of poor outcomes in lung cancer patients. As…”
Get full text

Efficacy and Safety of Nivolumab in Previously Treated Patients With Non–Small-cell Lung Cancer: Real World Experience in Argentina by Martin, Claudio, Lupinacci, Lorena, Perazzo, Florencia, Bas, Carlos, Carranza, Omar, Puparelli, Carmen, Kowalyszyn, Rubén, Magri, Ignacio, Varela, Mirta, Richardet, Eduardo, Vera, Karina, Foglia, Silvia, Jerez, Ignacio, Aman, Enrique, Martinengo, Gastón, Batagelj, Emilio, Dri, Alejandro, Pilnik, Norma, Roa, Guillermo M., Mando, Pablo, Tsou, Florencia, Recondo, Gonzalo, Cayol, Federico, Flores, Marcos, Sena, Susana, Bagnes, Claudia, Waisberg, Federico D., Minatta, José N., Rizzo, Manglio

“…Nivolumab was the first anti-programmed cell death 1 drug approved in Argentina for non–small-cell lung cancer treatment in the second-line setting. The…”
Get full text